Enterococcus UTI: High-Risk Populations
Enterococcal urinary tract infections predominantly occur in hospitalized patients with urinary catheters, recent antibiotic exposure, and urological abnormalities—particularly older males with obstructive uropathy or urinary retention.
Primary At-Risk Populations
The highest-risk patients for enterococcal UTI include 1, 2, 3:
Healthcare-Associated Risk Factors
- Catheterized patients (59.3% of enterococcal UTI cases) 1
- Recent antibiotic use within 3 months (51.8% of cases) 1
- Hospitalized patients, particularly in non-ICU wards (66.4%) 1
- Nosocomial infection setting (independent predictor) 3
Patient Demographics
- Male gender is an independent risk factor 2, 3
- Age 55-75 years represents peak risk 2
- Older adults (median age 61 years) 1
- Females still comprise 56.8% of cases overall, but males have disproportionately higher risk 1
Urological Factors
- Obstructive uropathy (independent predictor) 3
- Urinary retention 2
- Previous urinary instrumentation (OR 2.16) 4
- Indwelling urinary catheter (OR 2.05) 4
- Nephrostomy tubes 3
- Urological cancers 3
Special Considerations by Species
E. faecalis (77.3% of enterococcal UTIs) versus E. faecium (22.7%) show distinct patterns 1:
- E. faecium causes more severe disease with:
- Higher mortality (23% vs. 10.1%, p=0.002)
- Longer hospital stays (25 vs. 11.5 days, p<0.001)
- Greater antibiotic resistance
- Higher inflammatory markers (CRP 26.7 vs. 13 mg/dL)
Age-Specific Patterns in Males
In male outpatients, enterococcal UTI shows unique epidemiology 5:
- Young men (18-29 years) have 17% prevalence of E. faecalis in suspected UTI
- Recurrence rates increase with age: 12% (18-29 years) to 28% (≥70 years)
- Ciprofloxacin resistance rises with age: 22% (18-29 years) to 37% (≥70 years)
- E. faecalis is the second most common pathogen (16%) in male outpatient UTI
Clinical Implications for Risk Stratification
When to suspect enterococcal UTI:
- Complicated UTI in older males with catheters or recent instrumentation 4
- Healthcare-associated infections with prior antibiotic exposure 3
- Polymicrobial infections (E. faecalis isolated in 47% of polymicrobial UTIs in men) 5
- Immunocompromised patients with severe comorbidities 3
Important caveat: In pediatric patients with high-risk urological factors (CAKUT), enterococcal UTI is uncommon when nitrites are positive (only 1 of 24 cases), suggesting anti-enterococcal coverage may be unnecessary in this specific scenario 6.
Mortality Risk Factors
When enterococcal UTI occurs, mortality (16.5% overall) is associated with 3:
- SOFA score >4
- Immunosuppression
- Malignant hematologic disease
- E. faecium species (vs. E. faecalis)
- Ampicillin or vancomycin resistance
The combination of male gender, catheterization, recent antibiotics, and urological obstruction creates the highest-risk profile requiring empiric anti-enterococcal coverage 7, 2.